Advanced, personalized breast cancer screening using AI and imaging in community care
Official title: Advancing Risk-based Breast Cancer Screening and Surveillance in Community Practice
Funded at University of California at Davis · NIH-11535334 · Data updated 2026-11-12
A multicenter program is testing how AI-enhanced risk models and imaging can personalize breast cancer screening for women in everyday clinical settings.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | September 27, 2011 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $59,405 |
| NIH project number | 3P01CA154292-15S1 |
| Project ID | NIH-11535334 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women eligible for breast cancer screening who can access imaging services and have data to support risk modeling.
✕Less likely to help
Individuals with very low baseline risk or limited access to imaging resources may see no direct advantage.
What this research studies
This program aims to improve breast cancer screening by using AI with imaging and traditional risk factors to tailor screening intervals and methods. It investigates how to implement advanced risk models across clinics, while considering patient outcomes and potential harms. The effort also looks at patient, clinician, and facility factors that influence how risk-based screening is accepted and used in real-world communities.
Why it matters
Potential benefit: If successful, it could lead to more accurate, personalized screening plans that catch cancers earlier while reducing unnecessary procedures.
How similar studies have gone: Prior work shows promise for risk-based screening; this program seeks to expand to AI-enhanced models and population-level implementation.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Miglioretti, Diana L — University of California at Davis
- Study coordinator: Miglioretti, Diana L
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.